Oakworth Capital, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
Oakworth Capital, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$388,392
-0.9%
3,813
-1.8%
0.04%
+6.1%
Q2 2023$391,935
+8.3%
3,884
-1.3%
0.03%
+3.1%
Q1 2023$361,928
-4.1%
3,934
-5.5%
0.03%
-11.1%
Q4 2022$377,485
+19.5%
4,1610.0%0.04%
+2.9%
Q3 2022$316,000
-11.5%
4,161
-1.4%
0.04%
-2.8%
Q2 2022$357,000
-3.5%
4,2210.0%0.04%
+12.5%
Q1 2022$370,000
-6.3%
4,221
-6.6%
0.03%
-5.9%
Q4 2021$395,000
+6.8%
4,5210.0%0.03%
-5.6%
Q3 2021$370,000
-10.2%
4,5210.0%0.04%
-12.2%
Q2 2021$412,000
+6.7%
4,5210.0%0.04%
-6.8%
Q1 2021$386,000
-10.0%
4,521
-0.5%
0.04%
-21.4%
Q4 2020$429,000
+6.2%
4,544
-2.3%
0.06%
-15.2%
Q3 2020$404,000
+1.8%
4,649
+2.3%
0.07%
-7.0%
Q2 2020$397,000
+1.3%
4,544
-4.4%
0.07%
-22.8%
Q1 2020$392,000
-12.7%
4,7530.0%0.09%
+16.5%
Q4 2019$449,000
+4.4%
4,753
-3.9%
0.08%
-4.8%
Q3 2019$430,000
-12.1%
4,948
-7.5%
0.08%
-10.8%
Q2 2019$489,000
-4.9%
5,351
+0.2%
0.09%
-11.4%
Q1 2019$514,000
+12.2%
5,3420.0%0.10%
+1.0%
Q4 2018$458,000
-0.4%
5,3420.0%0.10%
+13.0%
Q3 2018$460,000
+2.4%
5,342
-10.1%
0.09%
-1.1%
Q2 2018$449,000
-1.5%
5,9450.0%0.09%
-14.7%
Q1 2018$456,000
-10.6%
5,9450.0%0.11%
-9.2%
Q4 2017$510,000
+1.8%
5,9450.0%0.12%
-7.0%
Q3 2017$501,000
+1.0%
5,9450.0%0.13%
-5.1%
Q2 2017$496,000
+12.2%
5,9450.0%0.14%
+6.2%
Q1 2017$442,000
-11.1%
5,945
-17.8%
0.13%
-21.5%
Q4 2016$497,000
-8.8%
7,228
+4.6%
0.16%
-13.8%
Q3 2016$545,000
-0.7%
6,9080.0%0.19%
-7.8%
Q2 2016$549,000
+11.8%
6,908
+1.9%
0.20%
+4.6%
Q1 2016$491,000
-15.8%
6,7760.0%0.20%
-19.3%
Q4 2015$583,000
-0.5%
6,776
+6.3%
0.24%
-21.1%
Q3 2015$586,000
-11.5%
6,3760.0%0.31%
-1.6%
Q2 2015$662,000
-17.5%
6,376
-19.0%
0.31%
-15.4%
Q1 2015$802,000
+9.9%
7,8760.0%0.37%
-2.1%
Q4 2014$730,000
+27.8%
7,876
+24.0%
0.38%
+12.8%
Q3 2014$571,000
-0.7%
6,3530.0%0.34%
-4.3%
Q2 2014$575,000
+6.5%
6,3530.0%0.35%
-0.8%
Q1 2014$540,000
+112.6%
6,353
+101.2%
0.35%
+96.1%
Q4 2013$254,0003,1580.18%
Other shareholders
NOVARTIS A G shareholders Q4 2016
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders